8/22/2013

Boulder, Colo.-based SomaLogic, which specializes in clinical diagnostics and protein biomarker discovery, has secured $10 million in a funding round. The funding comes the week after SomaLogic announced an agreement it struck with Agilent Technologies involving its SOMAscan platform for protein biomarker discovery.

Related Summaries